The marine actinomycete genus Salinispora is a remarkably prolific source of structurally diverse and biologically active secondary metabolites. Herein, we select the model organism Salinispora tropica CNB-440 for development as a heterologous host for the expression of biosynthetic gene clusters (BGCs) to complement well-established Streptomyces host strains. In order to create an integratable host with a clean background of secondary metabolism, we replaced three genes (salA-C) essential for salinosporamide biosynthesis with a cassette containing the Streptomyces coelicolor ΦC31 phage attachment site attB to generate the mutant S. tropica CNB-4401 via double-crossover recombination. This mutagenesis not only knocks-in the attachment site attB in the genome of S. tropica CNB-440 but also abolishes production of the salinosporamides, thereby simplifying the strain's chemical background. We validated this new heterologous host with the successful integration and expression of the thiolactomycin BGC that we recently identified in several S. pacifica strains. When compared to the extensively engineered superhost S. coelicolor M1152, the production of thiolactomycins from S. tropica CNB-4401 was approximately 3-fold higher. To the best of our knowledge, this is the first example of using a marine actinomycete as a heterologous host for natural product BGC expression. The established heterologous host may provide a useful platform to accelerate the discovery of novel natural products and engineer biosynthetic pathways.
Introduction
Microbially produced natural products are of paramount importance in human medicine. Not only are the majority of antimicrobial and anticancer drugs derived directly or inspired by natural products, many other branches of medicine, such as immunology, neurology, and cardiology, have similarly benefited from them (Newman and Cragg 2016) . Bacteria in the order Actinomycetales, commonly called actinomycetes, are the undisputed leading source for natural product discovery, accounting for approximately 75% of the microbial natural products used in human therapy (Berdy 2005) . Among the actinomycetes, the genus Streptomyces has been the major source of bioactive compounds discovered to date and has thus become the model organism for the study of natural product biosynthesis, pathway engineering, and genome mining (Baltz 2016; Chater 2016; Horinouchi 2007) . Recently, however, common soil-derived Streptomyces bacteria have fallen out of favor as a resource for drug discovery due in part to the common re-discovery of well-known compounds. This has led to a search for other Actinobacteria and the exploration of actinomycetes from poorly exploited environments such as the ocean (Jensen et al. 2005; Schorn et al. 2016) .
The marine actinomycete genus Salinispora was initially isolated from marine sediments and subsequently described as the first obligate marine actinomycete genus . Since then, Salinispora species have displayed the Electronic supplementary material The online version of this article (https://doi.org/10.1007/s00253-018-9283-z) contains supplementary material, which is available to authorized users. ability to produce a diverse range of secondary metabolites, including salinosporamide A, which is currently in clinical trials as an anticancer agent (Gulder and Moore 2010) . To date, 25 classes of compounds have been discovered from this genus, with 16 representing new carbon skeletons, correlating to virtually all known biosynthetic classes . Recent genome sequencing efforts have revealed that only a small fraction of the natural product biosynthetic potential of Salinispora species has been identified Letzel et al. 2017; Ziemert et al. 2014) . In a recent study, the genomes of 75 Salinispora strains were queried for nonribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) biosynthetic gene clusters (BGCs), revealing 124 distinct biosynthetic pathways predicted to encode 124 distinct natural products (Ziemert et al. 2014 ). This provides an unprecedented opportunity to explore the biosynthetic potential of Salinispora to discover new compounds.
Heterologous expression of whole BGCs has become a routine approach not only for the discovery of metabolites from Borphan^or Bcryptic^gene clusters (Ren et al. 2017; Rutledge and Challis 2015) , but also to probe biosynthetic logic involved in natural product biosynthesis (GomezEscribano and Bibb 2014; Ongley et al. 2013 ). This approach relies on two factors: first, the ability to clone BGCs into a suitable expression vector, and second, the availability of a compatible heterologous host. Recently, several wholepathway direct cloning approaches, such as full-length RecE-mediated recombination in E. coli (Fu et al. 2012) , transformation-associated recombination (TAR) in Saccharomyces cerevisiae (Kim et al. 2010; Yamanaka et al. 2014) , and Cas9-assisted in vitro assembly method (Jiang et al. 2015) , have been developed, and these have greatly accelerated the BGC isolation procedure. On the other hand, several Streptomyces strains have been established for heterologous expression of natural product biosynthesis genes (Gomez-Escribano and Bibb 2011; Komatsu et al. 2013 Komatsu et al. , 2010 . However, empirically, we have found that some Salinispora gene clusters, such as those encoding the salinosporamide ), lymphostin (Miyanaga et al. 2011) , and lomaiviticin pathways (Kersten et al. 2013) , are active in S. tropica strains but inactive when introduced to a Streptomyces heterologous host such as S. coelicolor or S. lividans. The expression of a BGC is a complicated cellular process that is highly dependent on the genetics and biochemistry of the producing organism (Baltz 2010) . We believe that the ability to easily test the expression of BGCs across various host organisms is a valuable asset to maximize the likelihood of achieving successful heterologous production of natural product small molecules . Therefore, establishing a biosynthetically versatile organism such as Salinispora as a heterologous host may facilitate the expression of additional BGCs for future discovery and engineering efforts.
S. tropica CNB-440 was the first whole genome-sequenced marine actinomycete and has been used as a model organism to investigate secondary metabolites (Udwary et al. 2007 ). So far, eight classes of compounds have been discovered from this strain alone, including the beta-lactone proteasome inhibitor salinosporamide A ) and the polyketide cytotoxin lomaiviticin A (Kersten et al. 2013) . Here, we report the engineering of S. tropica CNB-440 as a heterologous host by introducing the phage ΦC31 attachment site attB into the genome for integratable expression and simultaneously abolishing background salinosporamide production. The new Salinispora host is directly compatible with all previously established genetic toolkits leveraging the phage ΦC31 integrase for Streptomyces expression (Tang et al. 2015; Yamanaka et al. 2014) . We validated this new heterologous platform with the successful expression of the thiolactomycin BGC recently identified in several S. pacifica strains but absent in S. tropica (Tang et al. 2015) . To the best of our knowledge, this is the first showcase of the engineering and use of a marine actinomycete as a heterologous host for natural product pathway expression.
Materials and methods
Bacterial strains, plasmids, and culture conditions Chemicals and microbiological and molecular biological agents were purchased from standard commercial sources. Strains and plasmids used in this study are summarized in Table 1 . Salinispora tropica CNB-440 (ATCC BAA-916 and DSM 44818) and its respective derivatives were maintained and grown on A1 agar (10 g soluble starch, 4 g yeast extract, 2 g peptone, 16 g agar, 1 l natural or artificial seawater) and/or A1 liquid medium (10 g soluble starch, 4 g yeast extract, 2 g peptone, 1 l natural or artificial seawater). Escherichia coli strains were cultivated in LB medium (components purchased from BD Biosciences or Fisher Scientific) supplemented with the appropriate antibiotics. DNA isolation and manipulations were carried out according to standard methods for E. coli and Salinispora.
Construction of a gene disruption cassette containing the attB attachment site A 500-bp fragment containing the ΦC31 phage attachment site attB was amplified from the gDNA of Streptomyces coelicolor M1152 (Gomez-Escribano and Bibb 2011) with primers attBreg-F and attBreg-R (Table S1 ). The gene disruption cassettes acc(3)IV (Apra R ) and oriT RK2 were jointly amplified from pIJ773 (Gust et al. 2003) with the primers P1reg-F and P2reg-R (Table S1 ). These two PCR products were assembled by an overlap extension PCR using the primers attBreg-F and P2reg-R (Table S1 ). The final disruption cassette was further cloned into pCR™2.1-TOPO® vector (Fisher Scientific, Hampton, NH, USA) to give pMXT01 and was verified by restriction analysis and sequencing.
Gene replacement on the fosmid BHXS1782 containing the salinosporamide gene cluster
The disruption cassette containing the ΦC31 phage attachment site attB, acc(3)IV (Apra R ), and oriT RK2 was jointly amplified from the 1961-bp NotI/SpeI fragment of pMXT01 with the primer pair of salA-C_KO-F/salA-C_KO-R (Table S1 ). The PCR products were used to replace the genes salA-C on the fosmid BHXS1782 ) in E. coli BW25113/pKD20 (Datsenko and Wanner 2000) using the PCR targeting system. The resulting fosmid pMXT04 was confirmed by restriction analysis. Excision of the apramycin resistance cassette was performed in E. coli BT340 (Cherepanov and Wackernagel 1995) , taking advantage of the FLP recognition sites surrounding the resistance cassette. E. coli clones containing the fosmid pMXT10 were screened for apramycin sensitivity and verified by restriction analysis and PCR using the primer pair SalA-C-test650-F/SalA-Ctest650-R (Table S1 ). The chloramphenicol resistance marker cat on pMXT10 was replaced by the cassette containing oriT RK2 and aac(3)IV (Apra R ), which was amplified from pIJ773 with primers Cat-knockout-F1 and Cat-knockout-R1 (Table S1) , to give pMXT11.
Allelic exchange in Salinispora tropica CNB-440
The modified fosmid pMXT11 were introduced into E. coli ET12567/pUZ8002 (Paget et al. 1999 ) by electroporation and then transferred to S. tropica CNB-440 by conjugation. Apramycin resistant (Apra R ) exconjugants were identified, indicating a single-crossover allelic exchange in S. tropica CNB-440. Single colonies were picked and streaked on A1 agar plates without any antibiotics. Apramycin-sensitive colonies were further screened by PCR to obtain the doublecrossover allelic exchange mutant S. tropica CNB-4401. 
Invitrogen E. coli BW25113 Host strain for λ-RED recombination, K12 derivative: F-, Δ(araDaraB)567, ΔlacZ4787(::rrnB-3), λ-, rph-1, Δ(rhaD-rhaB)568, hsdR514
Datsenko and Wanner 2000
E. coli BT340 Host strain for FLP recombination: F-, Δ(argF-lac)169, ϕ80dlacZ58(M15), glnV44(AS), λ-, rfbC1, gyrA96(NalR), recA1, endA1, spoT1, thi-1, hsdR17, pCP20
Cherepanov and Wackernagel 1995 E. coli ET12567 DNA methylation deficient donor strain for conjugation: F2 dam13::Tn9, dcm, 6 hsdM, hsdR, recF143, zjj-202::Tn10, galK2, galT22 ara-14, laacY1, xyl-5, leuB6, thi-1, tonA31, rpsL 136, hisG4, tsx-78, mtl-1, glnV44 Flett et al. 1997 Heterologous expression of the thiolactomycin gene cluster
The plasmid pMXT13 (Tang et al. 2015) , containing the thiolactomycin BGC (tlm), was transferred into E. coli ET12567 and introduced into S. tropica CNB-4401 by triparental intergeneric conjugation with the help of E. coli ET12567/pUB307 (Flett et al. 1997) . Two hundred microliters overnight culture of E. coli was inoculated into 10-ml fresh LB medium plus appropriate antibiotics and grown for 3-4 h at 37°C until an OD600 of 0.4 was reached. The cells were washed twice with 10 ml of LB to remove antibiotics and resuspended in 0.5 ml of LB. Simultaneously, 10 μl ( 10 8 ) of S. tropica spores was added to 200-μl A1 broth and heat shocked at 50°C for 10 min. The spore suspension was mixed with 100 μl E. coli ET12567/pMXT13 and 100 μl E. coli ET12567/pUB307. The mixture was plated on an A1 agar plate and incubated at 30°C for 16-20 h. Each plate was then overlaid with 1 ml water containing 4 mg nalidixic acid (to selectively kill E. coli) and 2 mg kanamycin (for selection of mutants). Following incubation at 30°C for 7-9 days, kanamycin-resistant clones were selected, confirmed by PCR, and designated as S. tropica CNB-4401/tlm.
Production, extraction, and detection of salinosporamide A and thiolactomycins
Five milliliters of A1 medium was inoculated with 10-μl (10 8 ) spore suspension of S. pacifica CNS-863, S. tropica CNB-440, S. tropica CNB-4401, or a derivative thereof. The cultures were incubated for 3-4 days at 30°C at 220 rpm. One milliliter of preculture was inoculated into 50-ml A1 medium using wide bore pipet tips. The cultures were incubated for 9 days at 30°C with 220-rpm shaking. S. coelicolor M1152/ tlm was cultured as described previously (Tang et al. 2015) . The culture supernatant was adjusted to pH 4 with acetic acid and subsequently extracted with an equal volume of ethyl acetate. The organic phase was evaporated, and extracts were dissolved in 0.5 mL methanol (MeOH) and filtered through Acrodisc MS PTFE Syringe filters (Pall Inc., Ann Arbor, MI, USA) prior to HPLC and LC-MS analysis. For HPLC analysis, 10 μl of the MeOH extract was injected into an Agilent 1200 series analytical HPLC system monitored by UV lamp using a Luna 100A-C18 column (5 μm, 250 × 4. , fixed collision energy 20 eV; sourcegas temperature 300°C, gas flow 11 l/min; nebulizer 45 psig, ion polarity positive; scan source parameters-VCap 3000, Fragmentor 100, Skimmer 65, OctopoleRFPeak 750. The MS was autotuned using Agilent tuning solution in positive mode before each measurement. LC(DAD) data were analyzed with ChemStation software (Agilent), and MS data were analyzed with MassHunter software (Agilent).
Results
Adaptation of the ɸC31 int/attP-attB integration system in S. tropica CNB-440 ɸC31 integrase, a site-specific bacteriophage serine recombinase, catalyzes the insertion of a DNA fragment containing an attP site into a chromosomal attB site via recombination (Smith et al. 2010) . As attB sites are widely distributed in a broad range of Streptomyces species (Combes et al. 2002; Smith et al. 2004 ), ɸC31 int/attP has been heavily employed in constructing vectors such as pSET152 (Flett et al. 1997 ), pCAP01 (Yamanaka et al. 2014) , and pCAP03 (Tang et al. 2015 ) that can be integrated into the chromosome of various Streptomyces species for stable maintenance. In contrast to terrestrial Streptomyces, marine Salinispora species lack the attB attachment site in their genomes (Lechner et al. 2011 ). Previously, we identified three pseudo-attB sites in the genome of S. tropica CNB-440 that were used to integrate a ɸC31 phage-based vector carrying a single gene (Lechner et al. 2011 ). However, despite multiple attempts, we could not obtain exconjugants upon transfer of ɸC31 phage-based vectors carrying modest or large size BGCs (> 30 kb) into S. tropica CNB-440. This observation is consistent with an earlier study, which reported that insertion into the attB site is 300 times more efficient than into a pseudo-attB site (Combes et al. 2002) .
We thus decided to introduce an authentic attB site into the chromosome of S. tropica CNB-440 by RP4-mediated intergeneric conjugation. We first amplified a 500-bp DNA fragment containing the attB site from the gDNA of Streptomyces coelicolor M1152. The PCR product was assembled with a cassette amplified from plasmid pIJ773 (Gust et al. 2003 ) to obtain an attB-containing disruptive cassette with an attB site, aac(3)IV (Apra R ), oriT RK2 , and two terminal FLP recognition target (FRT) sequences ( Figure S1 ). This cassette was then cloned into pCR™2.1-TOPO® vector to form pMXT01 ( Figure S1 ). pMXT01 was digested with NotI/SpeI, and the 1961-bp fragment was purified by agarose gel electrophoresis to eliminate intact plasmid and used as a template for cassette amplification.
Deletion of endogenous BGCs has been used as a general strategy to (1) increase the metabolic flux of precursor availability and productivity of heterologously expressed BGCs and (2) simplify the identification and characterization of heterologous products by activity screening and metabolite profiling (GomezEscribano and Bibb 2011; Komatsu et al. 2010) . Thus, the fosmid BHXS1782 ) with a 44-kb insert containing the salinosporamide BGC (sal) was chosen to carry the attB-containing disruptive cassette into S. tropica CNB-440 to generate a double-crossover mutant. We first replaced assembly line biosynthesis genes salA to salC on the fosmid BHXS1782 with the attB-containing disruptive cassette by Red/ET-mediated recombination, generating the fosmid pMXT04 (Fig. 1) . Subsequently, the region of aac (3)IV (Apra R ) plus oriT RK2 was eliminated in vivo using FLPmediated recombination to form pMXT10 (Fig. 1) . Additionally, the cassette containing aac(3)IV (Apra R ) plus oriT RK2 was used to replace the chloramphenicol resistance gene cat, as aac (3)IV is a better selection marker for generating singlecrossover mutants in Salinispora and oriT RK2 is essential for E. coli-mediated conjugation. The resulting fosmid, pMXT11, was introduced into S. tropica CNB-440 by conjugation ( Figure S2 ). Single-crossover mutants were selected for their apramycin resistance. Intergeneric conjugation between E. coli ET12567/ pUZ8002/pMXT11 and S. tropica CNB-440 produced 10-20 colonies with apramycin resistance per conjugation using 10 μl (10 8 ) S. tropica spores. Although the efficiency is much lower than for conjugation with Streptomyces spores (10 4 -10 5 using 10 8 spores), this might be due to the high concentration of sea salt in the A1 agar plate, which is essential for the growth of S. tropica.
In order to obtain a double-crossover mutant, singlecrossover mutants were streaked for single colonies on A1 agar plates without antibiotics. Fifty colonies were tested for apramycin sensitivity, and strains no longer resistant to apramycin were obtained for further verification. Total DNA was isolated from selected colonies, and a pair of primers flanking salA-C was designed for PCR confirmation. As designed, amplification of a double-crossover deletion mutant gave a 626-bp PCR product (Fig. 2) . Furthermore, sequencing of the PCR product confirmed the presence of the attB site in the mutant strain, which was designated S. tropica CNB-4401. In the case of wild-type strain S. tropica CNB-440, no PCR products were obtained, as the targeted region was too large (9830 bp) (Fig. 2) .
We also compared the production of salinosporamide A, the major product of the sal BGC, from S. tropica CNB-440 and S. tropica CNB-4401. Because salA-C code for the salinosporamide enzymatic assembly line, S. tropica CNB-4401 should lose all ability to produce salinosporamide A.
After cultivation, extracts were subjected to high-resolution LC-ESI-MS analysis. In contrast to the wild-type strain S. tropica CNB-440, production of salinosporamide A (Fig. 2) and all other analogues was completely abolished in the double-crossover deletion mutant S. tropica CNB-4401. This result further confirmed the successful replacement of salA-C by the attB-containing disruptive cassette in the strain S. tropica CNB-4401. Additionally, the HPLC chromatogram of the ethyl acetate extract of the culture supernatant from S. tropica CNB-4401 contains a small number of peaks and a low baseline under various UV detection wavelengths ( Figure  S3 ). This would simplify downstream processes in detection and purification of heterologously produced metabolites.
Heterologous expression of an exogenous biosynthetic gene cluster in S. tropica CNB-4401
In order to assess the performance of S. tropica CNB-4401 as a heterologous host in expressing large BGCs, we selected the recently characterized BGC for the fatty acid synthase inhibitor thiolactomycin (tlm) that is only present in strains of S. pacifica. Other high-profile BGCs from Salinispora, such as the salinosporamide, lymphostin, and lomaiviticin BGCs, are endogenous to S. tropica CNB-440 and therefore were not selected for host validation. The tlm BGC encodes an unconventional polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) hybrid assembly line, which represents an important class of natural products (Tang et al. 2015) . Furthermore, the tlm genes were previously cloned into the integration vector pCAP03 to generate pMXT13 and successfully expressed in the Streptomyces coelicolor M1152 Bsuperhost,^albeit at lower levels than the wild-type producer (Tang et al. 2015; GomezEscribano and Bibb 2011) . Thus, the tlm BGC was directly introduced to the S. tropica CNB-4401 host via integration into the newly introduced genomic ɸC31 attB site. Kanamycinresistant clones were selected and designated S. tropica CNB-4401/tlm. Intergeneric conjugation among E. coli ET12567/ pUB307 (helper), E. coli ET12567/pMXT13, and S. tropica CNB-4401 yielded around 5 to 10 Kan R exconjugants (experiment in sextuplicate) per conjugation using 10 μl (10 8 ) S. tropica CNB-4401 spores ( Figure S4 ).
Although the integration efficiency is again much lower than that for Streptomyces spores, our data are comparable with the allelic exchange rate for making single-crossover mutants of S. tropica CNB-440 (10-20 mutants by biparental conjugation). This data thus supports the hypothesis that conjugation efficiency may be hampered by high salt concentrations necessary for the growth of some marine bacteria. No exconjugants were obtained from identical attempts to integrate the tlm BGC into the genome of S. tropica CNB-440 ( Figure S4 , experiment in sextuplicate). Therefore, our results strongly indicate that S. tropica CNB-4401 is capable of being readily integrated with large exogenous DNA fragments using the ɸC31 int/attP-attB integration system, while S. tropica CNB-440 is not. This strategy may be widely applicable in engineering other bacteria as integratable heterologous hosts that are directly compatible with established ɸC31-containing vectors (Martinez et al. 2004) .
With the successful integration of the tlm biosynthetic pathway in S. tropica CNB-4401, we cultured, extracted, and analyzed the supernatant extracts of the S. tropica CNB-4401/tlm heterologous host by HPLC and LC-MS. The production of thiolactomycin (1) and three analogues (10-methyl thiolactomycin (2), 11-methyl thiolactomycin (3), and thiotetromycin (4)) was identified from the extracts of S. tropica CNB-4401/tlm by comparison with thiolactomycins produced by the native producer S. pacifica CNS-863 as well as the heterologous producer S. coelicolor M1152/tlm. All four thiolactomycin analogues were previously fully characterized by 1D and 2D NMR experiments (Fig. 3) . Corresponding parent mass peaks for (1) with m/z 211.0789 [M+H] + (calcd for Figure S5 ). Thus, this is the first report of using the marine actinomycete Salinispora as an integratable host for natural product BGC heterologous expression.
In contrast to S. coelicolor M1152/tlm, the production of thiolactomycin (1) from S. tropica CNB-4401/tlm and S. pacifica CNS-863 was approximately 3-fold higher (Fig. 3) , while production of (3) and (4) were only slightly lower. Overall, the production pattern of the four thiolactomycin analogues in S. tropica CNB-4401/tlm was very similar to that of the native producer, S. pacifica CNS-863, and subtly different from that of S. coelicolor M1152 (Fig. 3) . This difference in production levels as well as PKS extender unit incorporation suggests that heterologous host context with respect to genetics, biochemistry, and metabolism influences heterologous thiolactomycin production and may also influence heterologous production of products associated with other BGCs.
Discussion
In this study, we selected S. tropica CNB-440 as the starting point for developing the first marine actinomycete heterologous host. In order to establish an integratable expression host with a cleaner background for convenient metabolic profiling, we introduced a disruptive cassette containing the well-established ΦC31 phage attachment site attB to replace three essential salinosporamide biosynthetic genes salA-C in S. tropica CNB-440. This newly established mutant strain S. tropica CNB-4401, therefore, possesses an authentic attB attachment site to integrate large exogenous BGCs through ɸC31 integrase activity for heterologous expression. We validated this new heterologous host with the successful integration and expression of the thiolactomycin BGC from several S. pacifica strains. To the best of our knowledge, this is the first example of using a marine actinomycete as a heterologous host for BGC expression.
The overall yield of all thiolactomycins produced heterologously by S. tropica CNB-4401 is very similar to the yield from the native producer S. pacifica CNS-863 and approximately 3 times higher than the yield from S. coelicolor M1152 (Fig. 3) . This is despite the fact that the S. coelicolor M1152 Bsuperhost^has been subjected to about a dozen rounds of genetic manipulation to delete endogenous pathways and introduce a point mutation to rpoB that has been empirically shown to enhance antibiotic production in Streptomyces (Gomez-Escribano and Bibb 2011).
The different ratios of compounds 1-4 observed between S. tropica CNB-4401/tlm (or S. pacifica CNS-863) and S. coelicolor M1152/tlm may be due to differences in methylmalonyl-CoA and ethylmalonyl-CoA precursor supply in these strains. However, previous gene deletion and heterologous expression experiments in S. coelicolor M1152 suggest that the pool of ethylmalonyl-CoA precursors used by the TlmH PKS to generate compounds 2-4 is primarily supplied by the pathway-specific crotonyl-CoA carboxylase (TlmB) and 3-hydroxybutyryl-CoA dehydrogenase (TlmC) ). Thus, there may be additional mechanisms beyond precursor supply that influence TlmH precursor utilization, which results in a different profile of thiolactomycin production levels in S. coelicolor M1152 compared to S. tropica CNB-4401 and S. pacifica CNS-863. This supports our previous finding that host context can play an important role in heterologous compound production and provide biosynthetic insights .
S. tropica expresses the unusual crotonyl-CoA carboxylase SalG that not only catalyzes the construction of ethylmalonylCoA, but also the unique PKS precursor chloroethylmalonylCoA ) and the rare propylmalonyl-CoA ). We employed LC-MS to interrogate thiolactomycin analogues that may have incorporated these alternate substrates, but no new thiolactomycin analogues were identified, perhaps due to substrate selectivity of the tlm PKS assembly line. Alternatively, insertion of a large DNA fragment into the engineered attachment site, which is upstream of the crotonyl-CoA carboxylase SalG, may cause polar effects that disrupt expression of salG. Heterologous expression of large BGCs remains challenging, particularly for pathways that require rare precursors and/or utilize uncertain regulatory, biosynthetic, or resistance factors. Our previous work to develop improved direct cloning and heterologous expression vectors demonstrated that having access to genetically diverse heterologous host organisms will enhance the likelihood of achieving successful heterologous expression for biosynthetic studies and identification of new compounds . As S. tropica CNB-4401 is a phylogenetically distinct actinomycete host that can now be easily leveraged using existing Streptomyces expression vectors for heterologous expression experiments, we believe that our study provides the natural product community an alternative and facile platform for discovering and engineering BGCs.
